Loading…

Inaccuracy of Thrombolysis in Myocardial Infarction and Global Registry in Acute Coronary Events scores in predicting outcome in ED patients with potential ischemic chest pain

Abstract Purpose The Thrombolysis in Myocardial Infarction (TIMI) and the Global Registry in Acute Coronary Events (GRACE) scores were largely evaluated and validated in stratifying risk of cardiovascular events in patients with chest pain and acute coronary syndrome. Our objective was to compare th...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of emergency medicine 2015-09, Vol.33 (9), p.1209-1212
Main Authors: Boubaker, Hamdi, MD, Beltaief, Kaouther, MD, Grissa, Mohamed Habib, MD, Kerkeni, Wièm, MD, Dridi, Zohra, MD, Msolli, Mohamed Amine, MD, Chouchène, Hamdène, MD, Belaïd, Alia, MD, Chouchène, Hamadi, MD, Sassi, Mohamed, MD, Bouida, Wahid, MD, Boukef, Riadh, MD, Methemmem, Mehdi, MD, Marghli, Soudani, MD, Nouira, Semir, MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Purpose The Thrombolysis in Myocardial Infarction (TIMI) and the Global Registry in Acute Coronary Events (GRACE) scores were largely evaluated and validated in stratifying risk of cardiovascular events in patients with chest pain and acute coronary syndrome. Our objective was to compare these 2 scores in predicting outcome in emergency department (ED) patients with undifferentiated chest pain. Materials and methods This was a prospective cohort study including patients presenting to 4 EDs with chest pain with nondiagnostic or normal ECG. For all included patients (n = 3125), TIMI and GRACE scores were calculated. Follow-up was conducted at 30-day and 1-year post-ED index admission to identify major adverse events. Main outcome included all cause mortality, acute coronary syndrome, and coronary non-ED planned revascularization. Prognostic performance of the scores was assessed by the receiver operating characteristic (ROC) curves. Results We reported 285 (9.1%) major adverse events at 30 days and 436 (13.9%) at 1 year. In patients with low TIMI (≤ 2) and GRACE (< 109) scores, a significant proportion had major adverse events at 30 days (5% and 7.5%, respectively) and 1 year (7.9% and 12.9%, respectively). Area under ROC curve at 30 days was 0.66 (95% confidence interval [CI], 0.62-0.71) vs 0.57 (95% CI, 0.53-0.62), respectively, for TIMI and GRACE scores. At 1 year, the area under ROC was 0.67 (95% CI, 0.62-0.71) and 0.65 (95% CI, 0.60-0.70), respectively, for TIMI and GRACE scores. Conclusions The TIMI and GRACE scores are not valid in short- and long-term risk stratification in our chest pain patients.
ISSN:0735-6757
1532-8171
DOI:10.1016/j.ajem.2015.05.019